Medsafe - Latest News [Page 1]

Medsafe introduces surgical mesh restrictions

Monday, 11 December 2017, 4:46 pm | Medsafe

Medsafe is taking action in New Zealand to remove from supply and effectively limit the use of certain surgical mesh products used for urogynaecological indications. More >>

New Zealand part of cross-border medicine control operation

Friday, 19 June 2015, 11:03 am | Medsafe

Medsafe says New Zealanders who choose to buy medicines online from overseas are continuing to run risks from substandard, illegal, or counterfeit medicines. More >>

Dangers of Purchasing Medicines over the Internet

Friday, 28 June 2013, 12:10 pm | Medsafe

Medsafe is warning about the dangers of buying medicines online following a joint Medsafe and Customs crackdown on substandard, illegal or counterfeit medicines. More >>

Hazard alert - Durom Acetabular Cup

Friday, 26 October 2012, 4:10 pm | Medsafe

Surgeons in New Zealand have been asked some months ago to carry out annual monitoring of all patients with metal-on-metal hip implants following alerts some devices need to be replaced earlier than expected. More >>

Smith and Nephew hip implant recalled worldwide

Friday, 8 June 2012, 4:37 pm | Medsafe

A hip implant with a metal liner is being recalled in New Zealand and worldwide by its overseas manufacturer. More >>

Recall announced of hip implant device

Friday, 13 April 2012, 8:33 pm | Medsafe

41 New Zealanders who received a MITCH THR hip implant device are being contacted by their surgeons after an international recall of the device. More >>

Medsafe warns of dangers of purchasing medicines online

Friday, 30 September 2011, 2:36 pm | Medsafe

Medsafe today reiterated its warning about the dangers of purchasing medicines online, citing that some websites sell medicines that may not be safe to use and could put people?s health at risk. More >>

Fifth patient level recall for 2010

Friday, 27 August 2010, 11:22 am | Medsafe

Medsafe has advised the Pharmacy Guild of New Zealand (the Guild) that there will be a patient level recall of one batch of Novo Nordisk’s GlucaGen® Hypokit 1mg injection. This is the fifth recall for 2010. More >>

Medsafe recalls four undeclared prescription meds

Friday, 13 August 2010, 10:54 am | Medsafe

Acting Director-General of Health Andrew Bridgman today advised consumers to immediately stop taking four products for erectile dysfunction or the enhancement of sexual performance which contain undeclared prescription medicines, citing significant health risks ... More >>

Sale restrictions on child cough, cold medicines

Tuesday, 8 June 2010, 4:54 pm | Medsafe

Cough and cold medicines for children under 12 years old will now be sold only in pharmacies except for those containing ingredients such as honey, lemon and other natural substances. More >>

Consumers warned of adulterated erectile pills

Friday, 7 May 2010, 10:49 am | Medsafe

Director-General of Health Stephen McKernan today advised consumers to immediately stop taking the following adulterated products for erectile dysfunction – SZM Formula for Men, Stallion, Volcanic and Tomcat Ali, citing significant health risks from ... More >>

Paradex and Capadex will be withdrawn from NZ

Friday, 26 March 2010, 11:04 am | Medsafe

On 1 August 2010, the consents to distribute medicines containing dextropropoxyphene (Capadex and Paradex) in New Zealand will be revoked. More >>

Websites Offering Unapproved Herbal Products

Monday, 23 November 2009, 1:56 pm | Medsafe

Medsafe today warned the public of 65 overseas websites that purport to be based in New Zealand and are touting unapproved herbal products. More >>

Close Monitoring of Apotex

Monday, 14 September 2009, 5:23 pm | Medsafe

The Ministry of Health’s drug regulatory arm Medsafe is closely monitoring Apotex, Canada’s largest medicines manufacturer, following the United States placing an import ban on medicines produced at two manufacturing sites by this company. The ... More >>

Medsafe approves additional levothyroxine products

Thursday, 23 October 2008, 4:49 pm | Medsafe

The Ministry of Health's drug regulatory arm Medsafe has given provisional approval to two products containing levothyroxine. This will allow patients in New Zealand to have access to an approved alternative to Eltroxin. More >>

Eltroxin formulation change

Friday, 27 June 2008, 11:50 am | Medsafe

Medsafe is writing to provide information and advice on the change in formulation of Eltroxin (levothyroxine, also known as, thyroxine) tablets which has led to a number of patients reporting problems such as sore eyes, palpitations, and headaches. More >>

Medsafe Orders Osteoarthritis Drug Withdrawal

Thursday, 20 December 2007, 4:33 pm | Medsafe

A review of the latest safety data on the osteoarthritis drug Prexige (lumiracoxib) has resulted in Medsafe withdrawing approval for the medicine and requiring the company that markets it to remove the product from the New Zealand market. More >>

Medsafe requests Ritalin SR be made available

Thursday, 27 September 2007, 2:03 pm | Medsafe

Following Medsafe concerns about the safety profile of the medicine Rubifen SR, Pharmac has announced it will make Ritalin SR available to people who experience serious side-effects following use of Rubifen SR, the subsidised brand of slow-release methylphenidate. More >>

Prexige 200mg and 400mg tablets to be withdrawn

Tuesday, 21 August 2007, 11:25 am | Medsafe

Consents allowing the supply of 200mg and 400mg tablets of the COX-2 anti-inflammatory medicine Prexige have been revoked in New Zealand by the Medicines and Medical Devices Safety Authority, Medsafe. More >>

New use of cancer therapy can halve risk of death

Friday, 10 November 2006, 3:30 pm | Medsafe

MedSafe registration approval has been given for a new use of a cancer treatment for patients diagnosed with indolent non-Hodgkin’s lymphoma (NHL). More >>

 

 

InfoPages Links

 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL